Park Avenue Securities’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$315K Buy
+4,027
New +$315K ﹤0.01% 1258
2025
Q1
Sell
-5,087
Closed -$377K 1282
2024
Q4
$377K Sell
5,087
-4,457
-47% -$330K ﹤0.01% 1191
2024
Q3
$630K Sell
9,544
-13,940
-59% -$920K 0.01% 885
2024
Q2
$2.17M Buy
23,484
+108
+0.5% +$9.98K 0.03% 390
2024
Q1
$2.23M Sell
23,376
-1,483
-6% -$142K 0.03% 385
2023
Q4
$1.9M Sell
24,859
-12,272
-33% -$935K 0.03% 394
2023
Q3
$2.57M Sell
37,131
-8,432
-19% -$584K 0.04% 267
2023
Q2
$4.3M Sell
45,563
-2,029
-4% -$191K 0.07% 185
2023
Q1
$3.94M Buy
47,592
+1,350
+3% +$112K 0.07% 181
2022
Q4
$3.45M Sell
46,242
-654
-1% -$48.8K 0.06% 197
2022
Q3
$3.88M Sell
46,896
-735
-2% -$60.7K 0.08% 162
2022
Q2
$4.53M Buy
47,631
+3,279
+7% +$312K 0.09% 146
2022
Q1
$5.22M Sell
44,352
-5,409
-11% -$637K 0.09% 121
2021
Q4
$6.45M Buy
49,761
+4,386
+10% +$568K 0.11% 109
2021
Q3
$5.14M Buy
45,375
+1,386
+3% +$157K 0.1% 104
2021
Q2
$4.56M Buy
43,989
+2,955
+7% +$306K 0.1% 105
2021
Q1
$3.43M Buy
41,034
+5,576
+16% +$466K 0.08% 122
2020
Q4
$3.24M Buy
35,458
+3,868
+12% +$353K 0.09% 104
2020
Q3
$2.52M Buy
31,590
+4,130
+15% +$330K 0.08% 109
2020
Q2
$1.9M Buy
+27,460
New +$1.9M 0.07% 125
2020
Q1
Sell
-23,937
Closed -$1.86M 385
2019
Q4
$1.86M Sell
23,937
-2,136
-8% -$166K 0.08% 107
2019
Q3
$1.91M Buy
+26,073
New +$1.91M 0.09% 90
2019
Q2
Sell
-21,912
Closed -$1.39M 316
2019
Q1
$1.39M Buy
+21,912
New +$1.39M 0.08% 93
2018
Q4
Sell
-16,923
Closed -$964K 219
2018
Q3
$964K Buy
16,923
+3,690
+28% +$210K 0.15% 44
2018
Q2
$645K Buy
13,233
+1,161
+10% +$56.6K 0.11% 61
2018
Q1
$545K Buy
12,072
+1,428
+13% +$64.5K 0.12% 62
2017
Q4
$396K Buy
10,644
+1,509
+17% +$56.1K 0.1% 61
2017
Q3
$335K Buy
9,135
+2,454
+37% +$90K 0.1% 60
2017
Q2
$262K Sell
6,681
-2,160
-24% -$84.7K 0.03% 157
2017
Q1
$278K Buy
+8,841
New +$278K 0.12% 33